Advent Life Sciences — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Aravivearavive.comOct 2022

BiotechHouston, US

Amato Giaccia(Director)Rudy Howard(Chief Financial Officer)Robert B. Geller(Chief Medical Officer)inGail McIntyre(Chief Executive Officer)Leonard Scott Dove(Chief Operating Officer)Joshua Brumm(Executive Officer)

Co-investors3E Bioventures Capital Eshelman Ventures, LLC

Proximieproximie.com in 𝕏Series C · Apr 2022 · $80M

Proximie provides a cloud-based operating system for connected operating rooms, giving medtech companies and hospitals real-time OR connectivity, structured surgical data, and AI-driven insights.

AI & Machine LearningDigital HealthMedical DevicesSaaSAltrincham

Nadine Hachach-Haram(Founder)inJonathan Lim(Director)inScott Huennekens(Director)in

BoardMohammed Shahzad Ahmed Malik(Director)

Co-investorsCapria Ventures Cedar Mundi Ventures COTU Ventures Draper Associates F-Prime Capital Questa Capital +6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Wondr Medical

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.